Eli Lilly reports 7.98% stake in Ionetix Corp

Eli Lilly and Company reports ownership of common stock of Ionetix Corp, a Delaware corporation with principal offices in Lansing, Michigan.

Rhea-AI Filing Summary

Eli Lilly and Company reports ownership of common stock of Ionetix Corp, a Delaware corporation with principal offices in Lansing, Michigan. Eli Lilly beneficially owns 8,411,397 shares of Ionetix common stock, representing 7.98% of the class.

Eli Lilly has sole power to vote and to dispose of all 8,411,397 shares, with no shared voting or dispositive power disclosed. The filing is signed by Christopher Anderson, Vice President – Leader of Corporate Securities and Assistant Corporate Secretary, on July 24, 2026.

Key Figures

Beneficial ownership: 8,411,397 shares Ownership percentage: 7.98% Sole voting power: 8,411,397 shares +2 more

5 metrics

Beneficial ownership 8,411,397 shares Common stock of Ionetix Corp beneficially owned by Eli Lilly

Ownership percentage 7.98% Percent of Ionetix Corp common stock class owned by Eli Lilly

Sole voting power 8,411,397 shares Shares of Ionetix over which Eli Lilly has sole power to vote

Sole dispositive power 8,411,397 shares Shares of Ionetix over which Eli Lilly has sole power to dispose

Par value per share $0.0001 per share Par value of Ionetix Corp common stock held by Eli Lilly

Key Terms

beneficially owned, sole voting power, sole dispositive power, Schedule 13G

4 terms

beneficially owned financial

"Item 4. | Ownership (a) | Amount beneficially owned: 8,411,397"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole voting power financial

"Sole Voting Power 8,411,397.00 6 | Shared Voting Power 0.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

sole dispositive power financial

"Sole Dispositive Power 8,411,397.00 8 | Shared Dispositive Power 0.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Schedule 13G regulatory

"form_type: "SCHEDULE 13G" in the filing metadata"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What percentage of Ionetix Corp (LLY-related filing) shares does Eli Lilly beneficially own?

Eli Lilly beneficially owns 7.98% of Ionetix Corp’s common stock. This corresponds to 8,411,397 shares with sole voting and dispositive power over all of those shares.

How many Ionetix Corp shares are reported as owned by Eli Lilly in this Schedule 13G?

Eli Lilly reports beneficial ownership of 8,411,397 Ionetix Corp common shares. It has sole power to vote and dispose of these 8,411,397 shares, with no shared authority indicated.

Does Eli Lilly share voting power over Ionetix Corp (LLY) shares in this filing?

No. Eli Lilly reports sole voting power over 8,411,397 shares of Ionetix Corp and no shared voting power. It likewise reports sole dispositive power over the same number of shares.

What is the class of securities Eli Lilly holds in Ionetix Corp related to LLY?

Eli Lilly holds common stock of Ionetix Corp with a par value of $0.0001 per share. The reported ownership interest is 8,411,397 shares, representing 7.98% of this class.

Who signed the Schedule 13G reporting Eli Lilly’s Ionetix Corp holdings?

The Schedule 13G is signed by Christopher Anderson, Vice President – Leader of Corporate Securities and Assistant Corporate Secretary of Eli Lilly, dated July 24, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/10/2026 - 01:38 PM Accepted by SEC EDGAR 07/24/2026 - 04:20 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Ionetix Corp / DE /

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

000000000

(CUSIP Number)

04/09/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 000000000

1

Names of Reporting Persons

ELI LILLY & Co

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

INDIANA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 8,411,397.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 8,411,397.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

8,411,397.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.9 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Ionetix Corp / DE /
(b)	Address of issuer's principal executive offices: 3130 SOVEREIGN DRIVE, LANSING, MICHIGAN, 48911.
Item 2.
(a)	Name of person filing: Eli Lilly and Company
(b)	Address or principal business office or, if none, residence: Lilly Corporate Center Indianapolis, Indiana 46285
(c)	Citizenship: Eli Lilly and Company is an Indiana corporation
(d)	Title of class of securities: Common Stock, par value $0.0001 per share
(e)	CUSIP Number(s): 000000000
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 8,411,397
(b)	Percent of class: 7.98%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 8,411,397
	(ii) Shared power to vote or to direct the vote: N/A
	(iii) Sole power to dispose or to direct the disposition of: 8,411,397
	(iv) Shared power to dispose or to direct the disposition of: N/A
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

ELI LILLY & Co

Signature:	/s/ Christopher Anderson
Name/Title:	Vice President - Leader of Corporate Securities and Assistant Corporate Secretary
Date:	07/24/2026